Depression and the affecting factors in patients with β Thalassemia Major having referred to Saravan city thalassemia center in 2017
Authors
Abstract:
Abstract Background and Objectives The chronic nature of thalassemia affects different aspects of patients' life and increases depression.The goal of the study was to determine depression and the affecting factors in patients with thalassemia major reffered to Saravan thalassemia center. Materials and Methods The population of this descriptive analytic study consisted of 60 thalassemic patients with the age range between 10 to 17 referred to Saravan thalassemia center; they were selected using the cenus sampling method. To collect data, the demographic and CDI questionnaires were used. Then, the data was analyzed by SPSS 23 with t-independent, one way anova test. Results Out of the total number of participants, 60% were female and 40% male. The mean age and and the depression score were 13.55 ± 1.89, 33.75 ± 5.43, respectively. The data analysis showed that all patients suffered from the varying range of depression. T independent test and one way anova test did not show a significant correlation with demographic information (p > 0.05). Conclusions Thalassemia patients suffer from varying degrees of depression. Therefore, programs and strategies are recommended for adaptation with the negative impacts of depression and its reduction.
similar resources
Prevalence of HCVAb and HBsAg in Patients with Beta-thalassemia Major in Amirkola Thalassemia Center
Background and purpose: Beta-thalassemia major is a genetic disorder with known globin defect that leads to chronic hemolytic anemia. Due to the need for recurrent blood transfusion, the risk of infectious diseases such as hepatitis is higher in these patients. Materials and methods: This cross-sectional study recruited 518 patients with thalassemia major in Amirkola Thalassemia Center, 2013-2...
full textEndocrinopathies in Thalassemia major patients in Thalassemia Center Jakarta, Indonesia
Background Regular transfusion in thalassemia major patients increases life expectancy and improves quality of life, but results in iron overload, which had toxic effects to organs including endocrine glands. The introduction of iron chelation therapy has reduced its toxicity, but complications may still occur. In Indonesia, most of our patients did not receive optimal iron chelation therapy, w...
full textSerum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included. References 1. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis 2010;5:13. 2. Blackwell RQ, Jim RT, Tan TG, Weng MI, Liu CS, Wang CL. Hemoglobin G Waimanalo: alpha-64 Asp lead...
full textTherapeutic approaches in patients with β-thalassemia
Beta-thalassemia (β-thal) is a congenital hemoglobinopathy explained by a decreased level (β+) or absence (βο) of β-globin gene expression. Microcytic hypochromic anemia and various clinical symptoms comprising severe anemia to clinically nonsymptomatic features. Treatment with an ordered blood transfusion and iron chelator agents can decrease transfusion iron overload that causes normal matura...
full textseroprevalence of hcv antibody among patients with β-thalassemia major in amirkola thalassemia center, iran
β- thalassemia major is a common hemoglobinopathy in humans. in some journals, numerous studies have reported different prevalence of hepatitis c among β- thalassemia major because thalassemic patients need multiple blood transfusions and blood transfusion is a common transmission pathway for hepatitis c virus. thus this study was performed for detection of anti-hcv between β- thalassemia major...
full textMy Resources
Journal title
volume 16 issue 2
pages 75- 81
publication date 2019-07
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023